Dyne Therapeutics, Inc Share Price: DYN (Dyne Therapeutics, Inc) Stock Price Today & Updates | INDmoney

Question 1

What is Dyne Therapeutics, Inc share price today?

Accepted Answer

Dyne Therapeutics, Inc (DYN) share price today is {{live_price}}.

Question 2

Can Indians buy Dyne Therapeutics, Inc shares?

Accepted Answer

Yes, Indians can invest in the Dyne Therapeutics, Inc (DYN) from India.

With INDmoney, you can buy Dyne Therapeutics, Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dyne Therapeutics, Inc at zero transaction cost.

Question 3

How can I buy Dyne Therapeutics, Inc shares from India?

Accepted Answer

It is very easy to buy Dyne Therapeutics, Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Dyne Therapeutics, Inc be purchased?

Accepted Answer

Yes, you can buy fractional shares of Dyne Therapeutics, Inc with INDmoney app.

Question 5

What are the documents required to start investing in Dyne Therapeutics, Inc stocks?

Accepted Answer

To start investing in Dyne Therapeutics, Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Dyne Therapeutics, Inc

Accepted Answer

Today’s highest price of Dyne Therapeutics, Inc (DYN) is {{1_rba_end}}.

Today’s lowest price of Dyne Therapeutics, Inc (DYN) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Dyne Therapeutics, Inc

Accepted Answer

Today's market capitalisation of Dyne Therapeutics, Inc DYN is 3.4B

Question 8

What is the 52 Week High and Low Range of Dyne Therapeutics, Inc

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Dyne Therapeutics, Inc is down from its 52 Week High?

Accepted Answer

Dyne Therapeutics, Inc (DYN) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Dyne Therapeutics, Inc is up from its 52 Week low?

Accepted Answer

Dyne Therapeutics, Inc (DYN) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Dyne Therapeutics, Inc?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Dyne Therapeutics, Inc

Accepted Answer

Ms. Susanna Gatti High M.B.A. is the current Chief Executive Officer (CEO) of Dyne Therapeutics, Inc.

Period	Dyne Therapeutics, Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	6.76%	5.1%	0.0%
6 Months	24.92%	4.9%	0.0%
1 Year	186.72%	16.6%	0.0%
3 Years	102.76%	13.2%	-22.3%

Market Capitalization	3.4B
Book Value	$7.74
Earnings Per Share (EPS)	-3.58
PEG Ratio	0.19
Wall Street Target Price	53.22

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-31.45%
Return On Equity TTM	-52.46%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-269.5M
Diluted Eps TTM	-3.58
Quarterly Earnings Growth YOY	0.0

Dyne Therapeutics, Inc (DYN)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Dyne Therapeutics, Inc Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-3.0
EPS Estimate Next Year	-3.28
EPS Estimate Current Quarter	-0.72
EPS Estimate Next Quarter	-0.73

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dyne Therapeutics, Inc	-21.71%	24.92%	186.72%	102.76%	38.2%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dyne Therapeutics, Inc	Buy	$3.4B	38.2%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Dyne Therapeutics, Inc
Employees	152
CEO	Ms. Susanna Gatti High M.B.A.
Industry	Commercial Services

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dyne Therapeutics, Inc	NA	NA	0.19	-3.0	-0.52	-0.31	NA	7.74
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26